Insider Buying: Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Acquires 1,500 Shares of Stock

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Catherine Cusack purchased 1,500 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The stock was bought at an average cost of $15.92 per share, with a total value of $23,880.00. Following the completion of the purchase, the director now owns 60,583 shares of the company’s stock, valued at $964,481.36. This represents a 2.54 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Catherine Cusack also recently made the following trade(s):

• On Friday, February 21st, Catherine Cusack acquired 1,000 shares of Sabra Health Care REIT stock. The shares were purchased at an average cost of $16.43 per share, for a total transaction of $16,430.00.

Sabra Health Care REIT Trading Down 0.2 %

NASDAQ SBRA opened at $16.39 on Thursday. Sabra Health Care REIT, Inc. has a 12 month low of $13.31 and a 12 month high of $20.03. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The stock’s fifty day moving average price is $16.78 and its 200-day moving average price is $17.62. The stock has a market cap of $3.90 billion, a P/E ratio of 30.93, a P/E/G ratio of 1.97 and a beta of 1.25.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.36. The company had revenue of $182.35 million for the quarter, compared to analysts’ expectations of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. As a group, equities analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Investors of record on Friday, February 14th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 7.32%. The ex-dividend date of this dividend is Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 226.42%.

Institutional Trading of Sabra Health Care REIT

Several institutional investors have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. raised its position in Sabra Health Care REIT by 4.5% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 15,369 shares of the real estate investment trust’s stock worth $286,000 after buying an additional 655 shares during the last quarter. Assetmark Inc. grew its stake in shares of Sabra Health Care REIT by 33.4% in the fourth quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock worth $45,000 after acquiring an additional 656 shares during the period. Janney Montgomery Scott LLC raised its holdings in shares of Sabra Health Care REIT by 0.4% during the fourth quarter. Janney Montgomery Scott LLC now owns 177,161 shares of the real estate investment trust’s stock valued at $3,068,000 after purchasing an additional 763 shares during the last quarter. Focus Partners Wealth lifted its position in Sabra Health Care REIT by 4.0% during the fourth quarter. Focus Partners Wealth now owns 20,771 shares of the real estate investment trust’s stock valued at $360,000 after purchasing an additional 797 shares during the period. Finally, Louisiana State Employees Retirement System boosted its holdings in Sabra Health Care REIT by 1.2% in the fourth quarter. Louisiana State Employees Retirement System now owns 65,700 shares of the real estate investment trust’s stock worth $1,138,000 after purchasing an additional 800 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and lowered their target price for the company from $18.00 to $17.00 in a research note on Friday, January 17th. Mizuho reissued a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. JMP Securities upgraded shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price on the stock in a report on Tuesday, January 7th. Finally, Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Three research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Sabra Health Care REIT currently has a consensus rating of “Moderate Buy” and an average price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.